FERG.UK

12,200

-1.29%ā†“

FERG.UK

12,200

-1.29%ā†“

FERG.UK

12,200

-1.29%ā†“

FERG.UK

12,200

-1.29%ā†“

FERG.UK

12,200

-1.29%ā†“

Search

ConvaTec Group PLC

Open

SectorFinanciƫn

256.8 1.02

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

251.6

Max

259.2

Belangrijke statistieken

By Trading Economics

Inkomsten

79M

Verkoop

1.1B

K/W

Sectorgemiddelde

36.743

22.015

EPS

0.07

Dividendrendement

1.96

Winstmarge

7.059

Werknemers

10,489

EBITDA

251M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+21.14% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.96%

3.90%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

203M

5.3B

Vorige openingsprijs

255.78

Vorige sluitingsprijs

256.8

Nieuwssentiment

By Acuity

50%

50%

223 / 542 Rangschikking in Finance

ConvaTec Group PLC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

26 feb 2025, 13:37 UTC

Marktinformatie

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

Peer Vergelijking

Prijswijziging

ConvaTec Group PLC Prognose

Koersdoel

By TipRanks

21.14% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 314.25Ā GBXĀ  21.14%

Hoogste 375Ā GBX

Laagste 282Ā GBX

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor ConvaTec Group PLC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

8 ratings

8

Buy

0

Hold

0

Sell

Sentiment

By Acuity

223 / 542 Rangschikking in Financiƫn

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.